Skip to main content
logo
GenSight Biologics S.A. (EPA:SIGHT)
France flag France · Delayed Price · Currency is EUR
0.0837
-0.0037 (-4.23%)
Oct 2, 2026, 5:35 PM CET

GenSight Biologics Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
-0.250.652.632.964.877.71
Revenue Growth
--75.16%-11.44%-39.07%-36.89%3.62%
Gross Profit
-0.250.652.632.964.877.71
Operating Income
-12.8-11.05-15.81-29.7-27.84-28.13
Net Income
-15.34-12.04-14-26.22-27.63-28.62
Earnings Per Share
-0.08-0.08-0.15-0.54-0.60-0.63
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1.672.422.462.1310.6144.29
Total Debt
12.8412.8614.4123.5417.8617.51
Net Cash (Debt)
-11.17-10.45-11.95-21.4-7.2526.78
Net Cash Growth
-----42.36%
Net Cash Per Share
-0.06-0.07-0.12-0.44-0.160.59

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-8.27-9.17-12.94-24.66-33.75-17.14
Capital Expenditures
-0.07-0-0-0.01-0.25-0.03
Free Cash Flow
-8.34-9.17-12.94-24.67-34.01-17.17
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
-100.00%100.00%100.00%100.00%100.00%
Operating Margin
--1695.40%-602.44%-1001.86%-572.15%-364.86%
Pretax Margin
6109.56%-1846.78%-532.57%-884.62%-567.73%-371.19%
Profit Margin
--1846.01%-533.37%-884.62%-567.83%-371.21%
FCF Margin
--1407.06%-492.88%-832.42%-698.97%-222.74%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
-78.1935.3112.598.6631.9033.13